Isoliquiritigenin inhibits NLRP3 inflammasome activation with CAPS mutations by suppressing caspase-1 activation and mutated NLRP3 aggregation.

Autor: Usui-Kawanishi F; Department of Pharmaceutical Engineering, Faculty of Engineering, Toyama Prefectural University, Imizu, Japan., Kani K; Department of Pharmaceutical Engineering, Faculty of Engineering, Toyama Prefectural University, Imizu, Japan., Karasawa T; Division of Inflammation Research, Center for Molecular Medicine, Jichi Medical University, Shimotsuke, Japan., Honda H; Toyama Prefectural Institute for Pharmaceutical Research, Imizu, Japan., Takayama N; Toyama Prefectural Institute for Pharmaceutical Research, Imizu, Japan., Takahashi M; Division of Inflammation Research, Center for Molecular Medicine, Jichi Medical University, Shimotsuke, Japan., Takatsu K; Toyama Prefectural Institute for Pharmaceutical Research, Imizu, Japan., Nagai Y; Department of Pharmaceutical Engineering, Faculty of Engineering, Toyama Prefectural University, Imizu, Japan.

Publikováno v: Genes to cells : devoted to molecular & cellular mechanisms [Genes Cells] 2024 May; Vol. 29 (5), pp. 423-431. Date of Electronic Publication: 2024 Feb 17.

Glucose regulates hypoxia-induced NLRP3 inflammasome activation in macrophages.

Autor: Watanabe S; Division of Inflammation Research, Center for Molecular Medicine, Jichi Medical University, Shimotsuke, Tochigi, Japan., Usui-Kawanishi F; Division of Inflammation Research, Center for Molecular Medicine, Jichi Medical University, Shimotsuke, Tochigi, Japan.; Department of Pharmaceutical Engineering, Toyama Prefectural University, Imizu, Toyama, Japan., Karasawa T; Division of Inflammation Research, Center for Molecular Medicine, Jichi Medical University, Shimotsuke, Tochigi, Japan., Kimura H; Division of Inflammation Research, Center for Molecular Medicine, Jichi Medical University, Shimotsuke, Tochigi, Japan., Kamata R; Division of Inflammation Research, Center for Molecular Medicine, Jichi Medical University, Shimotsuke, Tochigi, Japan., Komada T; Division of Inflammation Research, Center for Molecular Medicine, Jichi Medical University, Shimotsuke, Tochigi, Japan., Inoue Y; Division of Inflammation Research, Center for Molecular Medicine, Jichi Medical University, Shimotsuke, Tochigi, Japan., Mise N; Department of Environmental and Preventive Medicine, Jichi Medical University, Shimotsuke, Tochigi, Japan., Kasahara T; Division of Inflammation Research, Center for Molecular Medicine, Jichi Medical University, Shimotsuke, Tochigi, Japan., Takahashi M; Division of Inflammation Research, Center for Molecular Medicine, Jichi Medical University, Shimotsuke, Tochigi, Japan.

Publikováno v: Journal of cellular physiology [J Cell Physiol] 2020 Oct; Vol. 235 (10), pp. 7554-7566. Date of Electronic Publication: 2020 Mar 01.

Roles of Macrophages in Advanced Liver Fibrosis, Identified Using a Newly Established Mouse Model of Diet-Induced Non-Alcoholic Steatohepatitis.

Autor: Tada Y; Department of Pharmaceutical Engineering, Faculty of Engineering, Toyama Prefectural University, 5180 Kurokawa, Toyama 939-0398, Japan., Kasai K; Department of Pharmaceutical Engineering, Faculty of Engineering, Toyama Prefectural University, 5180 Kurokawa, Toyama 939-0398, Japan., Makiuchi N; Department of Pharmaceutical Engineering, Faculty of Engineering, Toyama Prefectural University, 5180 Kurokawa, Toyama 939-0398, Japan., Igarashi N; Department of Pharmaceutical Engineering, Faculty of Engineering, Toyama Prefectural University, 5180 Kurokawa, Toyama 939-0398, Japan., Kani K; Department of Pharmaceutical Engineering, Faculty of Engineering, Toyama Prefectural University, 5180 Kurokawa, Toyama 939-0398, Japan., Takano S; Department of Pharmaceutical Engineering, Faculty of Engineering, Toyama Prefectural University, 5180 Kurokawa, Toyama 939-0398, Japan., Honda H; Toyama Prefectural Institute for Pharmaceutical Research, 17-1 Nakataikouyama, Toyama 939-0363, Japan., Yanagibashi T; Toyama Prefectural Institute for Pharmaceutical Research, 17-1 Nakataikouyama, Toyama 939-0363, Japan., Watanabe Y; Toyama Prefectural Institute for Pharmaceutical Research, 17-1 Nakataikouyama, Toyama 939-0363, Japan., Usui-Kawanishi F; Department of Pharmaceutical Engineering, Faculty of Engineering, Toyama Prefectural University, 5180 Kurokawa, Toyama 939-0398, Japan., Furusawa Y; Department of Pharmaceutical Engineering, Faculty of Engineering, Toyama Prefectural University, 5180 Kurokawa, Toyama 939-0398, Japan., Ichimura-Shimizu M; Department of Pathology and Laboratory Medicine, Tokushima University Graduate School of Biomedical Sciences, 3-8-15 Kuramoto-cho, Tokushima 770-8503, Japan., Tabuchi Y; Division of Molecular Genetics Research, Life Science Research Center, University of Toyama, 2630 Sugitani, Toyama 930-0194, Japan., Takatsu K; Toyama Prefectural Institute for Pharmaceutical Research, 17-1 Nakataikouyama, Toyama 939-0363, Japan., Tsuneyama K; Department of Pathology and Laboratory Medicine, Tokushima University Graduate School of Biomedical Sciences, 3-8-15 Kuramoto-cho, Tokushima 770-8503, Japan., Nagai Y; Department of Pharmaceutical Engineering, Faculty of Engineering, Toyama Prefectural University, 5180 Kurokawa, Toyama 939-0398, Japan.

Publikováno v: International journal of molecular sciences [Int J Mol Sci] 2022 Oct 31; Vol. 23 (21). Date of Electronic Publication: 2022 Oct 31.

Effect of the introduction of a management bundle for blood culture collection.

Autor: Minami K; Infection Control Center, Osaka Medical and Pharmaceutical University Hospital, Osaka, Japan; Department of Central Clinical Laboratory, Osaka Medical and Pharmaceutical University Hospital, Osaka, Japan. Electronic address: kenta.minami@ompu.ac.jp., Yamada T; Infection Control Center, Osaka Medical and Pharmaceutical University Hospital, Osaka, Japan; Department of Pharmacy, Osaka Medical and Pharmaceutical University Hospital, Osaka, Japan., Yoshioka K; Infection Control Center, Osaka Medical and Pharmaceutical University Hospital, Osaka, Japan., Kawanishi F; Infection Control Center, Osaka Medical and Pharmaceutical University Hospital, Osaka, Japan., Ogawa T; Infection Control Center, Osaka Medical and Pharmaceutical University Hospital, Osaka, Japan; Department of Microbiology and Infection Control, Osaka Medical and Pharmaceutical University, Osaka, Japan., Ukimura A; Infection Control Center, Osaka Medical and Pharmaceutical University Hospital, Osaka, Japan; Department of Central Clinical Laboratory, Osaka Medical and Pharmaceutical University Hospital, Osaka, Japan.

Publikováno v: American journal of infection control [Am J Infect Control] 2022 Jul; Vol. 50 (7), pp. 772-776. Date of Electronic Publication: 2021 Dec 02.

Association between history of HBV vaccine response and anti-SARS-CoV-2 spike antibody response to the BioNTech/Pfizer's BNT162b2 mRNA SARS-CoV-2 vaccine among healthcare workers in Japan: A prospective observational study.

Autor: Iwamoto M; Department of General Medicine, Osaka Medical and Pharmaceutical University Hospital, Takatsuki City, Osaka, Japan.; Department of Emergency and General Internal Medicine, Rakuwakai Marutamachi Hospital, Kyoto, Nakagyo Ward, Japan., Ukimura A; Department of General Medicine, Osaka Medical and Pharmaceutical University Hospital, Takatsuki City, Osaka, Japan.; Infection Control Center, Osaka Medical and Pharmaceutical University Hospital, Takatsuki City, Osaka, Japan., Ogawa T; Department of General Medicine, Osaka Medical and Pharmaceutical University Hospital, Takatsuki City, Osaka, Japan.; Infection Control Center, Osaka Medical and Pharmaceutical University Hospital, Takatsuki City, Osaka, Japan., Kawanishi F; Infection Control Center, Osaka Medical and Pharmaceutical University Hospital, Takatsuki City, Osaka, Japan., Osaka N; Department of Clinical Laboratory, Osaka Medical and Pharmaceutical University Hospital, Takatsuki City, Osaka, Japan., Kubota M; Department of Clinical Laboratory, Osaka Medical and Pharmaceutical University Hospital, Takatsuki City, Osaka, Japan., Mori T; Health Administration Center Osaka Medical and Pharmaceutical University, Takatsuki City, Osaka, Japan., Sawamura R; Health Administration Center Osaka Medical and Pharmaceutical University, Takatsuki City, Osaka, Japan., Nishihara M; Department of Pharmacy, Osaka Medical and Pharmaceutical University Hospital, Takatsuki City, Osaka, Japan., Suzuki T; Department of General Medicine, Osaka Medical and Pharmaceutical University Hospital, Takatsuki City, Osaka, Japan., Uchiyama K; Department of Pharmacy, Osaka Medical and Pharmaceutical University Hospital, Takatsuki City, Osaka, Japan.; Department of General and Gastroenterological Surgery, Osaka Medical and Pharmaceutical University Hospital, Takatsuki City, Osaka, Japan.

Publikováno v: PloS one [PLoS One] 2022 May 16; Vol. 17 (5), pp. e0268529. Date of Electronic Publication: 2022 May 16 (Print Publication: 2022).